|
市場調査レポート
商品コード
1312437
生検装置の世界市場の予測（～2030年）Biopsy Devices Market Forecast to 2030 |
||||||
|
|||||||
| 生検装置の世界市場の予測（～2030年） |
|
出版日: 2023年07月13日
発行: Market Research Future
ページ情報: 英文 80 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
世界の生検装置の市場規模は、調査期間中にCAGRで6.80%の健全な成長が予測されています。
当レポートでは、世界の生検装置市場について調査分析し、市場力学、地域とセグメントの分析、企業プロファイルなどを提供しています。
目次
第1章 イントロダクション
第2章 調査手法
第3章 市場力学
- 促進要因
- 抑制要因
- 機会
- 課題
- マクロ経済指標
第4章 市場要因の分析
- ポーターのファイブフォースモデル
第5章 世界の生検装置市場：製品タイプ別
- イントロダクション
- 生検銃
- 生検ガイドシステム
- 生検針
- 生検鉗子
- その他
第6章 世界の生検装置市場：用途別
- イントロダクション
- 手術生検
- 皮膚生検
- 針生検
- 骨髄生検
- がん診断
- その他
第7章 世界の生検装置市場：エンドユーザー別
- イントロダクション
- 病院
- 専門診療所
- 診断センター
- 学術・研究機関
- その他
第8章 世界の生検装置市場：地域別
- イントロダクション
- 米国
- 欧州
- アジア太平洋
- 中東・アフリカ
第9章 企業情勢
- イントロダクション
第10章 企業プロファイル
- ARGON MEDICAL DEVICES, INC.
- BD
- COOK MEDICAL
- C. R. BARD, INC.
- CREGANNA
- FOCAL THERAPEUTICS, INC.
- HOLOGIC, INC.
- INTEGRA LIFESCIENCES CORPORATION
- LEICA BIOSYSTEMS
- PRECISION BIOPSY, LLC
- SCION MEDICAL TECHNOLOGIES, LLC.
- その他
第11章 付録
LIST OF TABLES
- TABLE 1 GLOBAL BIOPSY DEVICES MARKET, 2020-2027 (USD MILLION)
- TABLE 2 GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)
- TABLE 3 GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
- TABLE 4 GLOBAL BIOPSY DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
- TABLE 5 GLOBAL BIOPSY DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
LIST OF FIGURES
- FIGURE 1 RESEARCH PROCESS
- FIGURE 2 PORTERS FIVE FORCES MODEL
- FIGURE 3 GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE
- FIGURE 4 GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION
- FIGURE 5 GLOBAL BIOPSY DEVICES MARKET, BY END USER
- FIGURE 6 GLOBAL BIOPSY DEVICES MARKET, BY REGION
- FIGURE 7 GLOBAL BIOPSY DEVICES MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
Biopsy Devises Market Forecast to 2030
Market Overview
Biopsy Devises Market is projected to register a healthy CAGR of 6.80% during the review period. The rising predominance of disease and expanding inclination for insignificantly obtrusive medical procedures are driving the market development.
A biopsy is a sort of demonstrative system used to track down both dangerous and non-destructive irregularities in the human body. The worldwide market for biopsy gadgets is projected to grow because of the rising occurrence of disease in the populace. For example, malignant growth is the second-driving reason for death in the US after coronary illness and is the essential driver of death in Canada. As per the American Disease Society, there were 693,000 malignant growth fatalities and 1.9 million new disease analyze in 2018. In North America, prostate malignant growth is the sickness that is most often analyzed in men, yet bosom disease keeps on being the most well-known disease in ladies. Cellular breakdown in the lungs keeps on being the main source of death in the two genders. One of the primary drivers of the populace's malignant growth frequencies rising is the quick change in way of life, as well as the admission of liquor and cigarette items.
Market Segmentation
Based on the type of product, the Biopsy Devices Market is segmented into biopsy guns, biopsy guiding systems, biopsy needles, biopsy forceps, localization wires, and others.
The global market for biopsy devices has been divided into submarkets for breast, prostate, liver, lung, gynecological, and other applications.
The global market for biopsy devices has been divided into several subsectors based on the method used for guidance, including stereotactic, MRI, CT, and ultrasound.
The global industry for biopsy equipment has been divided into hospitals and clinics, diagnostic and imaging centers, academic and research institutes, and others based on end-user.
Regional Analysis
The development of the North America Biopsy Gadgets market is credited to the high market entrance paces of state-of-the-art items, like vacuum-helped biopsy frameworks, and a rapidly rising market interest for expendable items.
North America Biopsy Gadgets market represents the biggest market share because of the presence of deep-rooted market players in the country, high market entrance paces of state-of-the-art items, like vacuum-helped biopsy frameworks, and a rapidly rising market interest for expendable items. The tendency for negligibly obtrusive techniques, an expansion in disease frequency universally, and government drives for conclusion in this region are the main impetuses behind the development of the biopsy instruments market.
The Asia-Pacific Biopsy Gadgets Market is supposed to develop at the most noteworthy rate from 2018 to 2030. This is because of the rising frequency of disease, the huge populaces in countries like China and India, the better medical services framework, expanded medical care spending and government drives, and the rising consideration of significant market members in the region are adding to the section's ascent.
Major Players
Argon Medical Devices (US), BD (US), Cook Medical (US), CONMED Corporation (US), Olympus Corporation (Japan), Hologic, Inc. (US), Cardinal Health Inc. (US), Integra LifeSciences (US), Medtronic plc (US), Mammotome (US), INRAD (US), and Trivitron Healthcare (India) are the major companies in the market.
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 DEFINITION
- 1.2 SCOPE OF STUDY
- 1.3 RESEARCH OBJECTIVE
- 1.4 ASSUMPTIONS & LIMITATIONS
- 1.5 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH PROCESS
- 2.2 PRIMARY RESEARCH
- 2.3 SECONDARY RESEARCH
3 MARKET DYNAMICS
- 3.1 DRIVERS
- 3.2 RESTRAINTS
- 3.3 OPPORTUNITIES
- 3.4 CHALLENGES
- 3.5 MACROECONOMIC INDICATORS
4 MARKET FACTOR ANALYSIS
- 4.1 PORTER'S FIVE FORCES MODEL
- 4.1.1 BARGAINING POWER OF SUPPLIERS
- 4.1.2 BARGAINING POWER OF CUSTOMER
- 4.1.3 INTENSITY OF COMPETITOR'S
- 4.1.4 THREAT OF NEW ENTRANTS
5 GLOBAL BIOPSY DEVICES MARKET, BY PRODUCT TYPE
- 5.1 INTRODUCTION
- 5.1.1 BIOPSY GUNS
- 5.1.2 BIOPSY GUIDANCE SYSTEM
- 5.1.3 BIOPSY NEEDLES
- 5.1.4 BIOPSY FORCEPS
- 5.1.5 OTHERS
6 GLOBAL BIOPSY DEVICES MARKET, BY APPLICATION
- 6.1 INTRODUCTION
- 6.1.1 SURGICAL BIOPSY
- 6.1.2 SKIN BIOPSY
- 6.1.3 NEEDLE BIOPSY
- 6.1.4 BONE MARROW BIOPSY
- 6.1.5 CANCER DIAGNOSIS
- 6.1.6 OTHERS
7 GLOBAL BIOPSY DEVICES MARKET, BY END USER
- 7.1 INTRODUCTION
- 7.1.1 HOSPITALS
- 7.1.3 SPECIALTY CLINICS
- 7.1.4 DIAGNOSTIC CENTERS ACADEMIC & RESEARCH INSTITUTES
- 7.1.5 ACADEMIC & RESEARCH INSTITUTES
- 7.1.6 OTHERS
8 GLOBAL BIOPSY DEVICES MARKET, BY REGIONS
- 8.1 INTRODUCTION
- 8.1.1 AMERICAS
- 8.1.1.1 NORTH AMERICA
- 8.1.1.2 SOUTH AMERICA
- 8.1.2 EUROPE
- 8.1.2.1 GERMANY
- 8.1.2.2 FRANCE
- 8.1.2.3 UK
- 8.1.2.4 ITALY
- 8.1.2.5 SPAIN
- 8.1.2.6 REST OF EUROPE
- 8.1.3 ASIA PACIFIC
- 8.1.3.1 JAPAN
- 8.1.3.2 CHINA
- 8.1.3.3 INDIA
- 8.1.3.4 REPUBLIC OF KOREA
- 8.1.3.5 REST OF ASIA PACIFIC
- 8.1.4 MIDDLE EAST & AFRICA
- 8.1.1 AMERICAS
9 COMPANY LANDSCAPE
- 9.1 INTRODUCTION
- 9.1.1 MERGERS ACQUISITIONS
- 9.1.2 COLLABORATIONS
- 9.1.3 RELEASE/NEW PRODUCT LAUNCHES
- 9.1.4 OTHER (EXPANSION, UPDATES, PARTNERSHIP)
10 COMPANY PROFILE
- 10.1 ARGON MEDICAL DEVICES, INC.
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.1.3 FINANCIALS
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.2 BD
- 10.2.1 OVERVIEW
- 10.2.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.2.3 FINANCIALS
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.3 COOK MEDICAL
- 10.3.1 OVERVIEW
- 10.3.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.3.3 FINANCIALS
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 SWOT ANALYSIS
- 10.4 C. R. BARD, INC.
- 10.4.1 OVERVIEW
- 10.4.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.4.3 FINANCIALS
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 SWOT ANALYSIS
- 10.5 CREGANNA
- 10.5.1 OVERVIEW
- 10.5.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.5.3 FINANCIALS
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 SWOT ANALYSIS
- 10.6 FOCAL THERAPEUTICS, INC.
- 10.6.1 OVERVIEW
- 10.6.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.6.3 FINANCIALS
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 SWOT ANALYSIS
- 10.7 HOLOGIC, INC.
- 10.7.1 OVERVIEW
- 10.7.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.7.3 FINANCIALS
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 SWOT ANALYSIS
- 10.8 INTEGRA LIFESCIENCES CORPORATION
- 10.8.1 OVERVIEW
- 10.8.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.8.3 FINANCIALS
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 SWOT ANALYSIS
- 10.9 LEICA BIOSYSTEMS
- 10.9.1 OVERVIEW
- 10.9.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.9.3 FINANCIALS
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 SWOT ANALYSIS
- 10.10 PRECISION BIOPSY, LLC
- 10.10.1 OVERVIEW
- 10.10.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.10.3 FINANCIALS
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 SWOT ANALYSIS
- 10.11 SCION MEDICAL TECHNOLOGIES, LLC.
- 10.11.1 OVERVIEW
- 10.11.2 PRODUCT/BUSINESS SEGMENT OVERVIEW
- 10.11.3 FINANCIALS
- 10.11.4 KEY DEVELOPMENTS
- 10.11.5 SWOT ANALYSIS
- 10.12 OTHERS
11 APPENDIX
